Personalized Cancer Care: Risk Prediction, Early Diagnosis, Progression, and Therapy.

Area of Science:

• Oncology
• Genomic Medicine
• Bioinformatics

Background:

• Genomic medicine, also known as precision medicine or oncology, aims to improve cancer diagnosis and treatment for individual patients.
• The Fritz-Bender Foundation Symposium convened experts to discuss the current state and future of this field.

Purpose of the Study:

• To explore the latest advancements in genomic medicine for cancer care.
• To discuss the integration of genomic data into clinical practice and evidence-based medicine.
• To address the social, ethical, and technical challenges in personalized oncology.

Main Methods:

• Focus on next-generation sequencing (NGS) technologies.
• Application of analytical computational methods for big data analysis and data mining.
• Discussion of translational research and evidence-based medicine development.

Main Results:

• Exploration of genetic profiling for patient risk prediction.
• Analysis of molecular profiling for tumors and metastases.
• Consideration of tumor-host microenvironment interactions, metabolism, and tumor evolution in therapy adaptation.
• Advancements in antibody targeting of intracellular proteins and their role in carcinogenesis.

Conclusions:

• Genomic medicine offers a pathway to more precise and personalized cancer care.
• Integration of advanced sequencing, big data analytics, and translational research is crucial.
• Addressing ethical and social implications is essential for the successful implementation of genomic oncology.